Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Humanwell Healthcare Receives NMPA Approval for Caplyta Generic in Schizophrenia Trial
August 26, 2025
Company
Clover Biopharmaceuticals Receives Termination Notice from GAVI for COVID-19 Vaccine Agreement
March 25, 2025
Company
Simcere Pharmaceutical Group Reports Steady Revenue Amid R&D Investment Shift
March 25, 2025
Company
Henlius Biotech Reports 6.1% Revenue Growth with Strong Oncology Product Sales
March 25, 2025
Company
Sichuan Kelun-Biotech Reports 25.5% Revenue Growth with Key Drug Approvals
March 25, 2025
Drug
Medical Device
China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
March 25, 2025
Company
Medical Device
Jenscare Scientific’s Ken Valve Receives NMPA Marketing Approval
March 25, 2025
Company
Drug
SineuGene Therapeutics’ SNUG01 Receives FDA Clearance for ALS Clinical Study
March 25, 2025
Company
Drug
GSK’s Nucala Accepted for EMA Review for COPD Treatment
March 25, 2025
Company
Deals
Opella and JD Healthcare Collaborate to Enhance Fatty Liver Awareness in China
March 25, 2025
Company
Deals
Chongqing Zhifei Acquires 51% Stake in Chenan Bio for RMB593 Million
March 25, 2025
Company
Drug
Shanghai Ark Biopharmaceutical’s AK0901 Meets Phase III Endpoints in ADHD Trial
March 25, 2025
1
2
…
211
212
213
214
215
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
